Evidence map›Paper›PMID 26541675›Full record

ArticleMolecular cancer2015

Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression.

Panagiotis Maragozidis, Eirini Papanastasi, Diana Scutelnic, Athina Totomi, Ioanna Kokkori, Sotirios G Zarogiannis, Theodora Kerenidi, Konstantinos I Gourgoulianis, Nikolaos A A Balatsos

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Panagiotis MaragozidisDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, Larissa, 412 21, Greece. pmarago@med.uth.gr.
Eirini PapanastasiDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, Larissa, 412 21, Greece. epapanastasi@yahoo.gr.
Diana ScutelnicDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, Larissa, 412 21, Greece. ditha2007@hotmail.com.
Athina TotomiDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, Larissa, 412 21, Greece. athinatotomi@gmail.com.
Ioanna KokkoriDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, Larissa, 415 00, Greece. kouirouxis@hotmail.gr.
Sotirios G ZarogiannisDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, Larissa, 415 00, Greece. szarog@med.uth.gr.
Theodora KerenidiDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, Larissa, 415 00, Greece. noraker@gmail.com.
Konstantinos I GourgoulianisDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, Larissa, 415 00, Greece. kgourg@med.uth.gr.
Nikolaos A A BalatsosDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, Larissa, 412 21, Greece. balatsos@bio.uth.gr.
University of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is the leading cause of cancer mortality worldwide, mainly due to late diagnosis, poor prognosis and tumor heterogeneity. Thus, the need for biomarkers that will aid classification, treatment and monitoring remains intense and challenging and depends on the better understanding of the tumor pathobiology and underlying mechanisms. The deregulation of gene expression is a hallmark of cancer and a critical parameter is the stability of mRNAs that may lead to increased oncogene and/or decreased tumor suppressor transcript and protein levels. The shortening of mRNA poly(A) tails determines mRNA stability, as it is usually the first step in mRNA degradation, and is catalyzed by deadenylases. Herein, we assess the clinical significance of deadenylases and we study their role on gene expression in squamous cell lung carcinoma (SCC).

methodsComputational transcriptomic analysis from a publicly available microarray was performed in order to examine the expression of deadenylases in SCC patient samples. Subsequently we employed real-time PCR in clinical samples in order to validate the bioinformatics results regarding the gene expression of deadenylases. Selected deadenylases were silenced in NCI-H520 and Hep2 human cancer cell lines and the effect on gene expression was analyzed with cDNA microarrays.

resultsThe in silico analysis revealed that the expression of several deadenylases is altered in SCC. Quantitative real-time PCR showed that four deadenylases, PARN, CNOT6, CNOT7 and NOC, are differentially expressed in our SCC clinical samples. PARN overexpression correlated with younger patient age and CNOT6 overexpression with non-metastatic tumors. Kaplan-Meier analysis suggests that increased levels of PARN and NOC correlate with significantly increased survival. Gene expression analysis upon PARN and NOC silencing in lung cancer cells revealed gene expression deregulation that was functionally enriched for gene ontologies related to cell adhesion, cell junction, muscle contraction and metabolism.

conclusionsOur results highlight the clinical significance of PARN and NOC on the survival in SCC diagnosed patients. We demonstrate that the enzymes are implicated in important phenotypes pertinent to cancer biology and provide information on their role in the regulation of gene expression in SCC. Overall, our results support an emerging role for deadenylases in SCC and contribute to the understanding of their role in cancer biology.

Indexed as

Carcinoma, Squamous CellCell Line, TumorComputational BiologyExoribonucleasesHumansKaplan-Meier EstimateLung NeoplasmsNuclear ProteinsPrognosisRepressor ProteinsRNA StabilityTranscription FactorscNOT6 protein, humanCNOT7 protein, humanExoribonucleasesnocturninNuclear ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID26541675
PMCPMC4635609
OpenAlexW2116930231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.